Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)
Caron A. Jacobson(Dana-Farber Cancer Institute), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Brian T. Hill(Cleveland Clinic), Patrick J. Stiff(Loyola University Medical Center), Jaeyeon Kim(Sidney Kimmel Cancer Center), Zahid Bashir(AstraZeneca (United Kingdom)), Remus Vezan(National University of Misiones), Frederick L. Locke(Moffitt Cancer Center), Ira Braunschweig(The University of Texas MD Anderson Cancer Center), Rong Chu(University of Arkansas for Medical Sciences), Olalekan O. Oluwole(Vanderbilt University), Abhinav Deol(Wayne State University), Adrian Bot(Unknown), John M. Timmerman(Sheba Medical Center), Lazaros J. Lekakis(University of Miami Hospital), Patrick M. Reagan(University of Rochester), David B. Miklos(Stanford University), Armin Ghobadi(Washington University in St. Louis), André Goy(Hackensack University Medical Center), Javier Muñoz(The University of Texas MD Anderson Cancer Center), Yi Lin, Umar Farooq(Wake Forest University), Lianqing Zheng(Florida State University), Peter A. McSweeney(Mesoblast (United States)), Ian W. Flinn(Tennessee Oncology), John M. Rossi(Amgen (United States)), Tanya Siddiqi(City Of Hope National Medical Center)
Cited by 52
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k